Addictions
Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Numéro 4, Avril 2015
Addictions
Page(s) 439 - 446
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20153104019
Publié en ligne 8 mai 2015
  1. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006 ; 29 : 565–598. [CrossRef] [PubMed]
  2. Koob G, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 2007 ; 164 : 1149–1159. [CrossRef] [PubMed]
  3. Gould TJ. Addiction and cognition. Addict Sci Clin Pract 2010 ; 5 : 4–14. [PubMed]
  4. Kelley AE. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 2004 ; 44 : 161–179. [CrossRef] [PubMed]
  5. Kendler KS, Myers J, Prescott CA. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch Gen Psychiatry 2007 ; 64 : 1313–1320. [CrossRef] [PubMed]
  6. Robison AJ, Nestler EJ. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 2011 ; 12 : 623–637. [CrossRef] [PubMed]
  7. Waddington CH. The strategy of the genes: a discussion of some aspects of theoretical biology. London : Allen and Unwin, 1957.
  8. Felsenfeld G. A brief history of epigenetics. Cold Spring Harb Perspect Biol 2014 ; 6 : a018200. [CrossRef]
  9. Day JJ, Sweatt JD. DNA methylation and memory formation. Nat Neurosci 2010 ; 13 : 1319–1323. [CrossRef] [PubMed]
  10. Ray-Gallet D, Gerard A, Polo S, Almouzni G. Variations sur le thème du code histone. Med Sci (Paris) 2005 ; 21 : 384–389. [CrossRef] [EDP Sciences] [PubMed]
  11. Kim DH, Saetrom P, Snove O, Jr, Rossi JJ. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci USA 2008 ; 105 : 16230–16235. [CrossRef]
  12. Lister R, Mukamel EA, Nery JR, et al. Global epigenomic reconfiguration during mammalian brain development. Science 2013 ; 341 : 1237905. [CrossRef] [PubMed]
  13. Kim JK, Samaranayake M, Pradhan S. Epigenetic mechanisms in mammals. Cell Mol Life Sci 2009 ; 66 : 596–612. [CrossRef] [PubMed]
  14. Wang Y, Leung FC. An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics 2004 ; 20 : 1170–1177. [CrossRef] [PubMed]
  15. LaPlant Q, Vialou V, Covington HE 3rd et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat Neurosci 2010 ; 13 : 1137–1143. [CrossRef] [PubMed]
  16. Pol Bodetto S, Carouge D, Fonteneau M, et al. Cocaine represses protein phosphatase-1Cbeta through DNA methylation and methyl-CpG binding protein-2 recruitment in adult rat brain. Neuropharmacology 2013; 73 : 31–40. [CrossRef] [PubMed]
  17. Anier K, Malinovskaja K, Aonurm-Helm A, et al. DNA methylation regulates cocaine-induced behavioral sensitization in mice. Neuropsychopharmacology 2010 ; 35 : 2450–2461. [CrossRef] [PubMed]
  18. Guo JU, Su Y, Zhong C, et al. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011 ; 145 : 423–434. [CrossRef] [PubMed]
  19. Lewis JD, Meehan RR, Henzel WJ, et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992 ; 69 : 905–914. [CrossRef]
  20. Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999 ; 23 : 185–188. [CrossRef] [PubMed]
  21. Tudor M, Akbarian S, Chen RZ, Jaenisch R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci USA 2002 ; 99 : 15536–15541. [CrossRef]
  22. Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998 ; 393 : 386–389. [CrossRef] [PubMed]
  23. Adkins NL, Georgel PT. MeCP2: structure and function. Biochem Cell Biol 2011 ; 89 : 1–11. [CrossRef] [PubMed]
  24. Lyst MJ, Ekiert R, Ebert DH, et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat Neurosci 2013 ; 16 : 898–902. [CrossRef] [PubMed]
  25. Deschatrettes E, Jouvert P, Zwiller J. Overexpression of cyclic GMP-dependent protein kinase reduces MeCP2 and HDAC2 expression. Brain Behav 2012 ; 2 : 732–740. [CrossRef] [PubMed]
  26. Ausio J, Paz AM, Esteller M. MeCP2: the long trip from a chromatin protein to neurological disorders. Trends Mol Med 2014 ; 20 : 487–498. [CrossRef] [PubMed]
  27. Carouge D, Host L, Aunis D, et al. CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol Dis 2010 ; 38 : 414–424. [CrossRef] [PubMed]
  28. Adachi M, Monteggia LM. Decoding transcriptional repressor complexes in the adult central nervous system. Neuropharmacology 2014; 80C : 45–52. [CrossRef]
  29. Pol Bodetto S, Romieu P, Sartori M, et al. Differential regulation of MeCP2 and PP1 in passive or voluntary administration of cocaine or food. Int J Neuropsychopharmacol 2014; 17 : 1–14. [CrossRef] [PubMed]
  30. Skene PJ, Illingworth RS, Webb S, et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell 2010 ; 37 : 457–468. [CrossRef] [PubMed]
  31. Cassel S, Carouge D, Gensburger C, et al. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 2006 ; 70 : 487–492. [CrossRef] [PubMed]
  32. Host L, Dietrich JB, Carouge D, et al. Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition. J Psychopharmacol 2011 ; 25 : 222–229. [CrossRef] [PubMed]
  33. Im HI, Hollander JA, Bali P, Kenny PJ. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 2010 ; 13 : 1120–1127. [CrossRef] [PubMed]
  34. Deng JV, Rodriguiz RM, Hutchinson AN, et al. MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants. Nat Neurosci 2010 ; 13 : 1128–1136. [CrossRef] [PubMed]
  35. Lacoste N, Cote J. Le code épigénétique des histones. Med Sci (Paris) 2003 ; 19 : 955–959. [CrossRef] [EDP Sciences] [PubMed]
  36. Kumar A, Choi KH, Renthal W, et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005 ; 48 : 303–314. [CrossRef] [PubMed]
  37. Shibasaki M, Mizuno K, Kurokawa K, Ohkuma S. L-type voltage-dependent calcium channels facilitate acetylation of histone H3 through PKCgamma phosphorylation in mice with methamphetamine-induced place preference. J Neurochem 2011 ; 118 : 1056–1066. [CrossRef] [PubMed]
  38. Pandey SC, Ugale R, Zhang H, et al. Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci 2008 ; 28 : 3729–3737. [CrossRef] [PubMed]
  39. Renthal W, Maze I, Krishnan V, et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 2007 ; 56 : 517–529. [CrossRef] [PubMed]
  40. Dietrich JB, Takemori H, Grosch-Dirrig S, et al. Cocaine induces the expression of MEF2C transcription factor in rat striatum through activation of SIK1 and phosphorylation of the histone deacetylase HDAC5. Synapse 2012 ; 66 : 61–70. [CrossRef] [PubMed]
  41. Renthal W, Kumar A, Xiao G, et al. Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 2009 ; 62 : 335–348. [CrossRef] [PubMed]
  42. Romieu P, Host L, Gobaille S, et al. Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci 2008 ; 28 : 9342–9348. [CrossRef] [PubMed]
  43. Warnault V, Darcq E, Levine A, et al. Chromatin remodeling: a novel strategy to control excessive alcohol drinking. Transl Psychiatry 2013 ; 3 : e231. [CrossRef] [PubMed]
  44. Malvaez M, Sanchis-Segura C, Vo D, et al. Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry 2010 ; 67 : 36–43. [CrossRef] [PubMed]
  45. Pastor V, Host L, Zwiller J, Bernabeu R. Histone deacetylase inhibition decreases preference without affecting aversion for nicotine. J Neurochem 2011 ; 116 : 636–645. [CrossRef] [PubMed]
  46. Legastelois R, Botia B, Naassila M. Blockade of ethanol-induced behavioral sensitization by sodium butyrate: descriptive analysis of gene regulations in the striatum. Alcohol Clin Exp Res 2013 ; 37 : 1143–1153. [CrossRef] [PubMed]
  47. Romieu P, Deschatrettes E, Host L, et al. The inhibition of histone deacetylases reduces the reinstatement of cocaine-seeking behavior in rats. Curr Neuropharmacol 2011 ; 9 : 21–25. [CrossRef] [PubMed]
  48. Sun J, Wang L, Jiang B, et al. The effects of sodium butyrate, an inhibitor of histone deacetylase, on the cocaine- and sucrose-maintained self-administration in rats. Neurosci Lett 2008 ; 441 : 72–76. [CrossRef] [PubMed]
  49. Sanchis-Segura C, Lopez-Atalaya JP, Barco A. Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. Neuropsychopharmacology 2009 ; 34 : 2642–2654. [CrossRef] [PubMed]
  50. Shen HY, Kalda A, Yu L, et al. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice. Neuroscience 2008 ; 157 : 644–655. [CrossRef] [PubMed]
  51. Tesone-Coelho C, Morel LJ, Bhatt J, et al. Vulnerability to opiate intake in maternally deprived rats: implication of MeCP2 and of histone acetylation. Addict Biol 2015 ; 20 : 120–131. [CrossRef] [PubMed]
  52. Anne M, Sammartino D, Barginear MF, Budman D. Profile of panobinostat and its potential for treatment in solid tumors: an update. Onco Targets Ther 2013 ; 6 : 1613–1624. [CrossRef] [PubMed]
  53. Gorwood P. Les addictions sous l’angle de la génétique. Med Sci (Paris) 2015 ; 31 : 432–438. [CrossRef] [EDP Sciences] [PubMed]
  54. Morange M. Quelle place pour l’épigénétique ?. Med Sci (Paris) 2005 ; 21 : 367–369. [CrossRef] [EDP Sciences] [PubMed]
  55. Mahfoudhi E, Secardin L, Scourzic L, et al. Propriétés et rôles biologiques des protéines TET au cours du développement et de l’hématopoïèse. Med Sci (Paris) 2015 ; 31 : 268–274. [CrossRef] [EDP Sciences] [PubMed]
  56. La Herve D. drogue : une histoire d’histone ? Med Sci (Paris) 2010 ; 26 : 568–571. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.